Based on the prediction of computer-aided algorithms, the tumor suppressor gene, Pdcd4, has been validated as a miR-21 target in human urothelial carcinoma and glioblastoma cells [14], [58]. The gene discussed is PDCD4; the disease is urothelial carcinoma.